Showing 1,101 - 1,120 results of 1,880 for search '(( 10 ((meters decrease) OR (((nn decrease) OR (a decrease)))) ) OR ( 1 i decrease ))*', query time: 0.17s Refine Results
  1. 1101
  2. 1102
  3. 1103
  4. 1104
  5. 1105

    Ratings of perceived exertion misclassify intensities for sedentary older adults during graded cycling test: Effect of supramaximal high-intensity interval training by Jabbour G.

    Published 2018
    “…The intervention elicited physiological changes at rest and submaximal intensities, while no improvements were noted for both groups in aerobic fitness (i.e., V?O2peak). For both groups, RPE decreases with SCE at 10 min following graded test correlated significantly to V?…”
    Get full text
    Get full text
  6. 1106
  7. 1107
  8. 1108
  9. 1109
  10. 1110

    Consumption of some food groups is associated with the risk of cardiovascular disease among Jordanians by Tayyem, Reema

    Published 2020
    “…Case and controls were matched by age and gender with 1:1 ratio. Standardized and validated questionnaires were used to collect socio-demographic, health, lifestyle, and dietary data. …”
    Get full text
    Get full text
  11. 1111

    Enhanced bioelectrochemical treatment of petroleum refinery wastewater with Labaneh whey as co-substrate by Mohanakrishna, Gunda

    Published 2020
    “…Among several concentrations of LW as co-substrate in the range of 5–30% (v/v) with PRW, 85:15 (PRW:LW) showed to have the highest power generation (power density (PD), 832 mW/m2), which is two times higher than the control with PRW as sole substrate (PD, 420 mW/m2). On the contrary, a maximum substrate degradation rate of 0.420 kg COD/m3-day (ξCOD, 63.10%), was registered with 80:20 feed. …”
    Get full text
    Get full text
  12. 1112
  13. 1113
  14. 1114
  15. 1115

    Salvia fruticosa Induces Vasorelaxation in Rat Isolated Thoracic Aorta: Role of the PI3K/Akt/eNOS/NO/cGMP Signaling Pathway by Anwar, M. Akhtar

    Published 2017
    “…Prior exposure to PI3K inhibitors, wortmannin (0.1 µM) or LY294002 (10 µM), decreased cGMP accumulation and attenuated the SF-induced vasorelaxation by approximately 50% (Rmax). …”
    Get full text
    Get full text
  16. 1116
  17. 1117
  18. 1118
  19. 1119
  20. 1120